Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma

American Journal of Clinical Pathology

Volumn 112, Issue 3, 1999, Pages 377-383

  Stanley, Michelle J ^a   Stanley, Michael W ^a   Sanderson, Ralph D ^b   Zera, Richard ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast; Carcinoma; Fibroadenoma; Invasion; Proteoglycan; Stroma; Syndecan

Indexed keywords

FIBROBLAST GROWTH FACTOR; SYNDECAN;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; METASTASIS; PRIORITY JOURNAL; STROMA; TUMOR VASCULARIZATION;

EID: 0033491136     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.3.377     Document Type: Article

References (35)

1. Iozzo R. Proteoglycans and neoplasia. Cancer Metastasis Rev. 1988;7:39-50.
2. Iozzo R, Cohen I. Altered proteoglycan gene expression and the tumor stroma. Experientia, 1993;49:447-455.
3. Inki P, Jalkanen M. The role of syndecan-1 in malignancies. Ann Rev Med. 1996;28:63-67.
4. Bernfield M, Kokenyesi R, Kato K, et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Ann Rev Cell Biol 1992;8:365-393.
5. Koda J, Rapraeger A, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells: cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem. 1985;260:8157-8162.
6. Salmivirta M, Mali M, Heino J, et al. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res. 1994;215:180-188.
7. Salmivirta M, Elenius K, Vainio S, et al. Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem. 1991;266:7733-7739.
8. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol. 1988;106:423-430.
9. Liebersbach B, Sanderson R. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem. 1994; 269:20013-20019.
10. Hayashi K, Hayashi M, Jalkanen M, et al. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues: a light and electron microscopic study. J Histochem Cytochem. 1987;35:1079-1088.
11. Vainio S, Jalkanen M, Bernfield M, et al. Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidney. Dev Biol 1992;152:221-232.
12. Stanley M, Liebersbach B, Liu W, et al. Heparan sulfate-mediated cell aggregation: syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem. 1995;270:5077-5083.
13. Steinfeld R, Van Den Berghe H, David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol. 1996;133:405-416.
14. Gallo R, Kim C, Kokenyesi R, et al. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol. 1996;107:676-683.
15. Leppa S, Mali M, Miettinen H, et al. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A. 1992; 89:932-936.
16. Rapraeger A, Jalkanen M, Bernfield M. Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol. 1986;103:2683-2696.
17. Kato M, Saunders S, Nguyen H, et al. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 1995;6:559-576.
18. Mali M, Andtfolk H, Miettinen H, et al. Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem. 1994;269:27795-27798.
19. Dvorak H. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650-1659.
20. Boutin E, Sanderson R, Bernfield M, et al. Epithelial-mesenchymal interactions in uterus and vagina alter the expression of the cell surface proteoglycan, syndecan. Dev Biol. 1991;148:63-74.
21. Vainio S, Lehtonen E, Jalkanen M, et al. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol. 1989;134:382-391.
22. Gallo R, Ono M, Povsic T, et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A. 1994;91:11035-11039.
23. Subramanian S, Fitzgerald M, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272:14713-14720.
24. Inki P, Stenback F, Talve L, et al. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation: loss of expression associated with malignant transformation. Am J Pathol 1991;139:1333-1340.
25. Inki P, Kujari H, Jalkanen M. Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest. 1992;66:314-323.
26. Inki P, Joensuu H, Grenman R, et al. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer. 1994;70:319-323.
27. Pulkkinen J, Penttinen M, Jalkanen M, et al. Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol (Stockh). 1997;117:312-315.
28. Sanderson RD, Sneed TB, Young LA, et al. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by the integral membrane proteoglycan, syndecan. J Immunol. 1992;148:3902-3911.
29. Sun X, Mosher DF, Rapreager A. Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem. 1989;264:2885-2889.
30. Dhodapkar MV, Abe E, Theus A, et al. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth and bone cell differentiation. Blood. 1998;91:2679-2688.
31. Vainio S, Jalkanen M, Vaahtokari A, et al. Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Dev Biol. 1991;147:322-333.
32. Elenius K, Vainio S, Laato M, et al. Induced expression of syndecan in healing wounds. J Cell Biol. 1991;114:585-595.
33. de Jong JS, van Diest PJ, van der Valk P, et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol. 1998;184:44-52.
34. de Jong JS, van Diest PJ, van der Valk P, et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. II: Correlation with proliferation and angiogenesis. J Pathol. 1998;184:53-57.
35. Kato M, Wang H, Kainulainen V, et al. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med. 1998;4:691-697.